Virus: Washington approves distribution of rapid test for individual use

The United States urgently authorized on Tuesday the marketing of a rapid test for individual use to detect Covid-19 and which provides the result in 30 minutes, as part of the fight against the pandemic.

The US Medicines Agency (FDA) has given the green light to this test, which can be used nasally by individuals aged at least 14 years old, if contamination with the coronavirus is suspected.

The test, produced by the company Lucira Health, and which is available on prescription from a doctor, provides the result within 30 minutes. According to the Lucira Health site, it costs less than $ 50.

“The FDA has cleared the first # COVID19 test which is self-administered and gives results at home. This is an important step forward that underscores our commitment to expanding access to testing, ”said FDA Chief Stephen Hahn.

An emergency clearance is a temporary or conditional clearance granted by the FDA to respond to an emergency situation such as a pandemic. It can be revoked or modified if new data on efficacy or safety appear later.

The FDA has already approved at the end of April and the beginning of May, the use of tests to be carried out at home but unlike the kit of Lucira Health, their results must be given by authorized laboratories.

As of Tuesday, the United States recorded a total of 11,340,563 cases of Covid-19 for 248,429 deaths, according to Johns Hopkins University which refers. The two balances are the heaviest at the global level.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.